Strategic acquisitions are strengthening the Pregnyl Market 2026

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Pregnyl Market From 2026 To 2030?

The observed growth during the historical period is primarily linked to the expanding application of HCG in fertility programs, the proliferation of IVF and ART clinics, its well-established function in addressing male hypogonadism, the development of clinical proficiency in hormone therapy, and the accessibility of injectable fertility medications.

The anticipated expansion throughout the forecast period is largely attributable to the escalating prevalence of infertility, the rising demand for assisted reproduction, broader access to fertility treatments, increasing awareness regarding male fertility, and the growing adoption of personalized hormone regimens.

Key trends observed for the forecast duration include an escalating demand for fertility hormone therapies, their increased utilization in assisted reproductive techniques, a heightened focus on male fertility treatments, an expansion in the applications of injectable hormones, and a greater emphasis on controlled hormone administration.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20262&type=smp

What Key Drivers Are Influencing The Growth Of The Pregnyl Market?

The pregnyl market is anticipated to grow as healthcare infrastructure expands. Healthcare infrastructure encompasses the physical and organizational frameworks, amenities, assets, and systems vital for providing health services to communities. This expansion is fueled by an aging global population, a rise in chronic illnesses, and advancements in technology. A robust healthcare infrastructure promotes pregnyl’s development by ensuring availability of fertility treatments, suitable storage, appropriate administration facilities, and skilled healthcare professionals. For example, in January 2024, the American Hospital Association, a professional organization in the US, reported that in 2024, the United States contained 6,120 hospitals, featuring 916,752 staffed beds and accommodating 33,679,935 total admissions across its facilities. Additionally, a May 2024 report from the UK’s Office for National Statistics indicated that total healthcare spending increased by 5.6% in nominal terms from 2022 to 2023, a significant rise compared to the 0.9% growth rate seen in 2022. Consequently, the expanding healthcare infrastructure is a key factor driving the pregnyl market’s growth. The Pregnyl market is projected to expand due to increasing infertility rates. Infertility is defined as the inability to conceive after 12 or more months of consistent unprotected sexual activity. The prevalence of infertility is growing as couples postpone having children until their late 30s, a period when natural fertility decreases. Pregnyl assists in managing infertility by aiding assisted reproductive techniques, either by inducing ovulation or by supporting the luteal phase. For example, in April 2023, the World Health Organization (WHO), a Switzerland-based intergovernmental agency of the United Nations, reported that around 17.5% of adults, approximately 1 in 6 individuals worldwide, experience infertility at some point in their lives, challenging prior assumptions about geographical differences. Consequently, the rising infertility rates are anticipated to fuel the growth of the Pregnyl market.

Which Segments Are Included In The Analysis Of The Pregnyl Market?

The pregnyl market covered in this report is segmented –

1) By Indication: Fertility Treatments In Women, Male Infertility, Hypogonadotropic Hypogonadism

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By End-User: Fertility Clinics, Research Institutions, Other End-Users

Which Trends Are Impacting The Growth Of The Pregnyl Market?

In July 2025, Organon & Co., a U.S.-based pharmaceutical firm, purchased Merck & Co., Inc.’s biotech manufacturing site at De Geer in Oss for an undisclosed sum. This acquisition enabled Organon to enhance its fertility drug manufacturing capabilities and ensure a steady supply of active ingredients for its fertility product range, which includes hCG-based items like Pregnyl. Merck & Co., Inc. operates as a Germany-based pharmaceutical company with a focus on innovative medicines, vaccines, and healthcare solutions across key therapeutic domains.

Which Key Industry Participants Are Active In The Pregnyl Market?

Major companies operating in the pregnyl market are Merck & Co.Inc.

Read the full pregnyl market report here:

https://www.thebusinessresearchcompany.com/report/pregnyl-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Pregnyl Market?

North America was the largest region in the pregnyl market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pregnyl market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Pregnyl Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20262&type=smp

Browse Through More Reports Similar to the Global Pregnyl Market 2026, By The Business Research Company

Injection Pen Market Report 2026

https://www.thebusinessresearchcompany.com/report/injection-pen-global-market-report

Disposable Syringes Market Report 2026

https://www.thebusinessresearchcompany.com/report/disposable-syringes-global-market-report

Diabetes Pen Market Report 2026

https://www.thebusinessresearchcompany.com/report/diabetes-pen-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795